Shilajit vs Tongkat Ali: Testosterone, Evidence & Stacking (2026)

How do shilajit and tongkat ali compare head-to-head?

Shilajit and tongkat ali target testosterone through different mechanisms: shilajit supports mitochondrial CoQ10 stability and mineral transport via fulvic acid, while tongkat ali acts on the HPG axis and cortisol reduction via quassinoids. Tongkat ali has more pooled RCT data specifically for testosterone (five trials in a 2022 meta-analysis). Shilajit has broader evidence across testosterone, exercise fatigue, and bone health.

Shilajit vs tongkat ali comparison (yourhealthier.com)

Factor	Shilajit	Tongkat Ali
Source	Mineral resin from Himalayan rock	Root extract of Eurycoma longifolia tree (Southeast Asia)
Key bioactive	Fulvic acid (50-80%)	Eurycomanone (quassinoid compound)
Proposed testosterone mechanism	Mineral transport, mitochondrial energy support, antioxidant protection	LH-mediated Leydig cell stimulation, cortisol reduction via HPA axis modulation
Testosterone RCTs	1 RCT (n=96, 90 days, +20%)	5 RCTs pooled in 2022 meta-analysis; significant increase confirmed
Non-testosterone evidence	Exercise, bone density, fertility, female sexual function, collagen	Cortisol reduction, stress/mood in stressed populations, some erectile function data
Cortisol effect	Not directly measured in trials	Several studies report cortisol reduction in stressed individuals
ED evidence	No direct ED trial	One 6-month RCT (concurrent training + tongkat ali improved IIEF-5 scores)
Female evidence	1 RCT (FSFI improvement); 1 RCT (bone density)	1 RCT on menopausal quality of life (Physta); limited
Dose	250-500 mg/day (standardized extract)	200-400 mg/day (standardized to eurycomanone)
Onset	8-12 weeks	2-12 weeks (varies by trial)
Key safety risk	Heavy metals from geological source	Quality variation; potential insomnia at high doses
Can be stacked?	Theoretically yes (different mechanisms). No trial has tested the combination.

What is tongkat ali?

Tongkat ali (Eurycoma longifolia) is a flowering plant native to Southeast Asia whose root extract has been used in traditional medicine for centuries as a tonic for vitality and male sexual health. The primary bioactive compound is eurycomanone, a quassinoid.

Unlike shilajit, which works broadly through mineral transport and antioxidant mechanisms, tongkat ali's proposed action is more specific to the hormonal axis. It appears to stimulate luteinizing hormone (LH) production, which in turn signals Leydig cells in the testes to produce more testosterone. It may also modulate the hypothalamic-pituitary-adrenal (HPA) axis, reducing cortisol levels in stressed individuals. Cortisol and testosterone have an inverse relationship: chronically high cortisol suppresses testosterone production, so lowering cortisol can indirectly support testosterone levels.

The standardized extract most studied in clinical trials is Physta, a water-soluble root extract standardized to eurycomanone content. When evaluating tongkat ali products, look for this standardization, since generic "tongkat ali root powder" may contain very different (and much lower) levels of the active compound.

Which has stronger testosterone evidence — shilajit or tongkat ali?

Tongkat ali has a numerically stronger evidence base for testosterone, with five RCTs pooled in a 2022 systematic review and meta-analysis. Shilajit has one well-designed RCT from one research group.

Tongkat ali: Leisegang et al. (2022) conducted a systematic review and meta-analysis of nine studies (five RCTs eligible for pooling) examining Eurycoma longifolia as a sole intervention for testosterone levels. The meta-analysis found a statistically significant increase in total testosterone (SMD = 1.352, p = 0.001), confirmed in the hypogonadism subgroup (Medicina, PubMed). The evidence is stronger than any single study because it pools data across multiple groups and settings.

Shilajit: Pandit et al. (2016) gave 500 mg/day to 96 healthy men aged 45 to 55 for 90 days. Total testosterone rose ~20%, free testosterone ~19% versus placebo (PubMed). This is a well-designed single RCT, but it has not been independently replicated by a separate research group.

On testosterone evidence alone, tongkat ali is ahead. However, "ahead" means "further along a still-early evidence path." Neither compound has the large-scale, multi-center confirmatory trials that would be needed to call either a proven testosterone intervention. Both are promising but preliminary. A 2024 systematic review of testosterone-booster supplements by a team of urologists concluded that most marketed products lack rigorous verification of their claimed testosterone benefits, which applies to herbal options on both sides of this comparison (Morgado et al., 2024, International Journal of Impotence Research, PubMed). For the full shilajit evidence audit, see does shilajit actually work.

Where does shilajit have more clinical data than tongkat ali?

Shilajit's advantage is breadth. While tongkat ali's trial data clusters around testosterone and cortisol, shilajit has published RCTs across a wider range of outcomes.

Exercise and muscular strength: Keller et al. (2019) showed that shilajit preserved muscular strength under fatigue in 63 men over 8 weeks (PubMed). Tongkat ali does not have a comparable exercise-performance trial, though some cortisol-reduction data could be tangentially relevant to recovery.

Bone density in women: Pingali et al. (2022) ran a 48-week trial in 60 postmenopausal women showing dose-dependent bone mineral density preservation (PubMed). Tongkat ali has one RCT on menopausal quality of life but no bone data.

Female sexual function: Mosavi et al. (2023) found significant FSFI improvements in women taking shilajit for 60 days (DOI). Tongkat ali's female data is limited.

Male fertility: Biswas et al. (2010) reported a 61% increase in sperm count in subfertile men (PubMed). Tongkat ali has some semen-parameter data but less directly comparable.

If your interest is narrowly testosterone, tongkat ali has more supporting data. If your interest spans testosterone, exercise, bone health, fertility, and women's health, shilajit covers more ground. See shilajit benefits for men for the male-specific picture.

Where does tongkat ali have more clinical data than shilajit?

Tongkat ali has published data in two areas where shilajit does not: cortisol reduction and erectile function (in combination with exercise).

Cortisol: Several tongkat ali trials have measured cortisol as an outcome and found reductions in stressed populations. Shilajit's adaptogenic properties are discussed in reviews (Stohs et al., 2014, PubMed), but no shilajit trial has measured cortisol directly.

Erectile function: One 6-month RCT tested 200 mg/day of tongkat ali combined with concurrent training in 45 men with androgen deficiency of aging males (ADAM). The group receiving both interventions showed significant improvement on the IIEF-5 (erectile function score). The limitation is that you cannot separate the tongkat ali effect from the exercise effect, since both contributed. Shilajit has no direct ED trial data at all. See shilajit and sexual health for the full picture.

Can you take shilajit and tongkat ali together?

Their mechanisms do not overlap, which makes stacking theoretically rational. Shilajit acts on mineral transport and mitochondrial energy; tongkat ali acts on the HPG axis and cortisol. In principle, they could support testosterone from two different angles simultaneously.

No clinical trial has tested this combination. The safety of the stack is unknown beyond the individual safety profiles of each compound at standard doses. If you choose to stack, use products with verified doses and third-party testing for both, and consult your doctor if you take any medication affecting hormones, blood pressure, or blood sugar.

A practical concern: adding two "testosterone support" supplements does not double your testosterone. Biological systems have feedback loops. If one supplement modestly raises testosterone, the body may partially compensate, limiting what a second supplement can add. Stacking should be approached with realistic expectations, not additive math.

Who should choose which?

The choice depends on what you are optimizing for.

Choose shilajit if you want broader health coverage (testosterone plus exercise, bone density, fertility, mineral absorption), if you are a woman seeking evidence-based supplementation, or if fulvic acid's mineral-transport mechanism aligns with your health goals. Shilajit is the better pick for general wellness beyond testosterone alone. For our tested capsule, see Shilajit Adaptogen Complex.

Choose tongkat ali if your primary goal is testosterone support and you want the compound with more pooled RCT data behind that specific claim, or if cortisol reduction is a priority (relevant for high-stress individuals whose cortisol may be suppressing testosterone).

Consider both if you have the budget, both products are third-party tested, and you understand that the combination is untested and results are not guaranteed to be additive.

Choose neither if you have clinically diagnosed hypogonadism. Both are supplements with modest effects. Low testosterone that causes symptoms needs medical evaluation and potentially testosterone replacement therapy, not herbal supplements. See your doctor first.

Why did YourHealthier formulate with shilajit instead of tongkat ali?

We chose shilajit because its evidence extends beyond testosterone to mitochondrial support, collagen preservation, and mineral transport — a broader mechanism profile for a general wellness product. Tongkat ali is a strong testosterone-specific ingredient, but its narrower evidence base made it a less versatile formulation anchor.

We chose shilajit for our Adaptogen Complex because its evidence spans more outcomes than testosterone alone, and its fulvic acid mechanism (mineral transport, mitochondrial support, antioxidant activity) aligns with our broader wellness positioning. Tongkat ali is a legitimate supplement with real data, and we may consider it in future formulations. For now, shilajit's combination of breadth, mechanism, and E-E-A-T-strength clinical citations made it the stronger foundation for an evidence-first product. For the best shilajit supplements across the market, see our full comparison. For dosing protocol, see shilajit dosage. For timing, see best time to take shilajit.

Testing & Transparency Methodology

Every YourHealthier product is manufactured in an FDA-registered, UL Solutions GMP-certified facility and undergoes independent third-party testing for heavy metals and microbial contamination using validated USP, AOAC, and ICP-MS methods. Batch-specific certificates of analysis are published at yourhealthier.com/pages/lab-results. All testing complies with 21 CFR Part 111.

For a related stack, see the four-ingredient adaptogen stack.

What does the latest 2026 research add to this comparison?

Two 2026 developments shift the balance. Shilajit gained its first multicenter, placebo-controlled RCT (n=100, 90 days) showing robust strength and endurance improvements. Tongkat ali gained a negative result: a 4-week placebo-controlled trial in exercise-trained adults found no effect on testosterone, body composition, or strength. The evidence gap is narrowing, but in different directions for each compound.

The biggest 2026 update on the shilajit side is a multicenter RCT by Shah et al. (2026, medRxiv preprint, CTRI/2025/07/091323). One hundred healthy males aged 21–50 with at least one year of resistance training received either 500 mg/day of standardized shilajit resin or placebo for 90 days across four investigational sites. The shilajit group showed significantly greater improvements in 1RM leg press, muscle endurance, and handgrip strength (the largest secondary effect: +12.5% vs +7.9%, p=0.0002, d=0.77). Ninety-nine of 100 participants completed the trial — a 99% retention rate that strengthens the data. This is the largest and most rigorous shilajit exercise trial to date, and it moves shilajit's strength-and-endurance evidence from "one small controlled trial plus a pilot" to "two controlled trials including one multicenter."

On the tongkat ali side, the most notable 2024 publication was a negative result. An ISSN conference abstract reported a 4-week, placebo-controlled trial of 400 mg/day tongkat ali in exercise-trained males and females. The conclusion was direct: "Four weeks of supplementation with Tongkat Ali in exercise-trained males and females does not affect body composition, mood, sleep, vigilant attention, handgrip strength, cortisol, and free testosterone." This does not invalidate the positive meta-analysis (which pooled studies in hypogonadal and aging men), but it does confirm what the existing data already suggested — tongkat ali's testosterone effect is population-dependent and may not extend to younger, already-trained individuals with normal hormone levels.

A 2021 multicentre RCT (Chinnappan et al., PMID 34262417) tested Physta tongkat ali at 100 mg and 200 mg/day for 12 weeks in 105 older men (50–70 years) with low testosterone (below 300 ng/dL). Both doses significantly increased total testosterone, reduced fatigue scores (AMS and FSS), and increased muscle strength at week 12 compared to placebo. The 200 mg group showed effects as early as week 2. This is tongkat ali's strongest trial in its target population — aging hypogonadal men — and it demonstrates that the compound's effect is real in the right people at the right dose.

The practical update: shilajit's evidence is broadening (testosterone + strength + fatigue + bone + collagen), while tongkat ali's evidence is deepening in its core lane (testosterone in hypogonadal men) but failing to extend to broader populations. If you are an aging man with confirmed low testosterone, tongkat ali has more targeted data. If you are looking for a broader adaptogenic profile that touches mitochondrial function, connective tissue, and hormonal support simultaneously, shilajit covers more ground — and the 2026 multicenter trial significantly strengthened that case.

How do the safety profiles compare?

Both compounds are well-tolerated in published trials, but they carry different risk profiles. Shilajit's primary safety concern is heavy-metal contamination in unpurified products — a 2025 analysis found thallium in five of six commercial samples. Tongkat ali's concern is product adulteration and, at high doses, potential liver toxicity reported in case studies.

On the shilajit side, Kamgar et al. (2025) tested six commercially available shilajit products and detected thallium — a toxic heavy metal not included in standard supplement testing panels — in five of them (PMID 39827344). This is not a problem with shilajit as a compound; it is a problem with shilajit as a market. Purified, third-party tested products used in clinical trials (PrimaVie, TruBlk) passed safety screening. The takeaway: only buy shilajit with a batch-specific certificate of analysis from an accredited lab showing heavy-metal levels below USP limits. Our Shilajit Adaptogen Complex publishes batch COAs at yourhealthier.com/pages/lab-results.

On the tongkat ali side, a 2024 LiverTox review (National Institute of Diabetes and Digestive and Kidney Diseases, PMID 39527684) documented cases of liver injury associated with tongkat ali supplements, though the causal relationship was complicated by product adulteration and concurrent use of other supplements. Standardized water-soluble extracts (Physta, LJ100) used in clinical trials have not shown hepatotoxicity. The risk, like shilajit's heavy-metal risk, is primarily a product-quality problem rather than a compound-level problem. Both supplements demand careful sourcing.

References

Frequently asked questions